Back
Liberty Formula One Group Vs. Akero Therapeutics Industry Stock Comparison
Sell
41
FWONK
Liberty Formula One Group
Last Price:
68.97
Seasonality Move:
11.18%
Sell
25
AKRO
Akero Therapeutics
Last Price:
18.92
Seasonality Move:
16.15%
Sell
41
Liberty Formula One Group (FWONK)
is a Sell
Is Liberty Formula One Group a Buy, Sell or Hold?
- The current Liberty Formula One Group [FWONK] share price is $69.15. The Score for FWONK is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- FWONK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $20.26. The Score for AKRO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FWONK Stock Price Chart
What is Liberty Formula One Group's stock price today?
-
The Liberty Formula One Group share price today is $69.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FWONK is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $20.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
FWONK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 55.75 | Buy |
Chaikin Money Flow: | 206071 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.61 - 68.57) | Buy |
Bollinger Bands (100): | (63.54 - 69.36) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.21 | Sell |
Relative Strength Index (14 RSI): | 31.81 | Sell |
Chaikin Money Flow: | -465905 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.28 - 24.52) | Sell |
Bollinger Bands (100): | (20 - 26.08) | Sell |
FWONK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 68.23 | Buy |
20-day SMA: | 67.61 | Buy |
50-day SMA: | 68.59 | Buy |
200-day SMA: | 67.12 | Buy |
8-day EMA: | 68.5 | Buy |
20-day EMA: | 68.13 | Buy |
50-day EMA: | 67.89 | Buy |
200-day EMA: | 67.36 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.06 | Sell |
20-day SMA: | 22.39 | Sell |
50-day SMA: | 24.65 | Sell |
200-day SMA: | 29.08 | Sell |
8-day EMA: | 21.09 | Sell |
20-day EMA: | 22.3 | Sell |
50-day EMA: | 23.39 | Sell |
200-day EMA: | 27.61 | Sell |
Liberty Formula One Group Earnings Growth & FWONK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.12 per share, an increase this year of $0.25 per share, and an increase next year of $0.34 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Liberty Formula One Group Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |